Healthcare & Life Sciences
-

From Trailblazer to Portfolio Leader: What a Decade of Brand Growth Can Teach Us
Sustaining brand leadership requires more than a strong launch. Explore how evolving insights, shifting audiences, and deliberate strategy enable biopharma brands to grow from single products into enduring portfolios.
-

Lessons from the Field: Optimizing Public Health Communications
HawkPartners offers five examples to optimize public health communications materials
-

Will the COVID-19 Vaccine Roll Out Impact other Vaccine Brand Considerations in the Future?
The emergency-use authorizations of COVID-19 vaccines are priming consumers for vaccine brand differentiation and presenting a novel marketing situation that tasks marketers with challenging master brand decisions.
-

The Patient Journey to COVID-19 Vaccination
During a recent Advertising Research Foundation Pharma Council event, Robert Duboff moderated a discussion of how behavioral economics can provide greater insight into the COVID-19 patient journey.
-

Reinventing the House Call Through Telehealth
The current pandemic is tearing down the regulatory and reimbursement barriers that have prevented telehealth from realizing its full potential to date. Our team examines the value propositions of several…
-

Engaging with HCPs in The New Normal – A Roadmap for Success
HawkPartners developed a five-step framework to help pharma companies anticipate the “new normal” as a means of optimizing HCP engagement in a post-COVID-19 world.
-

Healthcare Decisioning: The Role of RWD and RWE
With the growing trend of real-world data and real-world evidence in healthcare, what can we expect moving forward? We explore these applications across the product life cycle and what it…
-

How Big Pharma is Gaining Momentum in Digital Health
Statistics and investments point to pharma companies’ integration of transformative technologies into ways of thinking and doing business. The infographic below, developed by Abbey Ahearn and Lucy Hale, demonstrates the rising…
-

Insights from Connected Health
Amidst explosive investment in digital health, the industry is working to keep the human side of care front and center.
-

Digital Healthcare: A Path Forward for Pharmaceutical Companies
Digital health offers tremendous upside for the pharmaceutical industry. In this infographic, we explore the challenges and opportunities ahead for pharma as it innovates to move closer to fully digitized…
-

2022 Health Vision: Digital Health’s Impact on How We Get and Stay Healthy
Abbey Ahearn shares her vision on the (near-term) future of consumer healthcare. Pills with sensors, digital therapeutics for addiction, and AI for early cancer detection are just a few of…
-

Latest Disruption in Healthcare
Three major companies Amazon, JP Morgan and Berkshire Hathaway announced hopes of fixing health care. Here are 4 themes we’ll be watching